Thalidomide inhibits the replication of human immunodeficiency virus type 1.
Thalidomide, a selective inhibitor of tumor necrosis factor alpha (TNF-alpha) synthesis, suppresses the activation of latent human immunodeficiency virus type 1 (HIV-1) in a monocytoid (U1) line. The inhibition is dose dependent and occurs after exposure of the cells to recombinant TNF-alpha, phorbo...
Kaydedildi:
| Yayımlandı: | Proc Natl Acad Sci U S A |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
National Academy of Sciences
1993
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC46849/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8327469/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.90.13.5974 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|